Carolin Helten

6PUBLICATIONS
4CO-AUTHORS
Toxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)Autonomic nervous systemBiomolecular modelling and designPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 21, 2025
Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1-induced platelet reactivity.

Philipp Mourikis, Marcel Benkhoff, Laura Wildeis

|Oct 21, 2024
Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease.

Marcel Benkhoff, Maike Barcik, Philipp Mourikis

|Nov 01, 2022
TAVR: nemesis of NOACs?

Amin Polzin, Carolin Helten, Daniel Metzen

|Nov 02, 2021
Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study.

Amin Polzin, Lisa Dannenberg, Carolin Helten

|Jan 29, 2021
Diabetes mellitus is not associated with enhanced bleeding risk in patients after percutaneous coronary intervention.

René M'Pembele, Daniel Metzen, Natalia Czychy

Pageof 1